Skip to content

Effect of pine bark extract on the treatment of patients with type 2 diabetes with microalbuminuria

The effect of pine bark extract supplementation on metabolic status , serum levels of ICAM-1 and VCAM-1 and anthropometric indeces in type 2 diabetic patients with microalbuminuria

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100408003664N21
Enrollment
46
Registered
2018-04-26
Start date
2018-03-21
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes with microalbuminuria. Type 2 diabetes mellitus with renal complications

Interventions

Intervention 1: Intervention group: Pine bark extract (Oligopin) will be taken as two capsules of 50 mg with a meal (breakfast and lunch) for 8 weeks, the product of Aramis Faramad Company. Interventi

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Volunteered to participate in the study with type 2 diabetes People (men and women) who have been diagnosed with diabetes for at least one year. Age:Women 30-50 years old Men: 30-65 years old Microalbuminuria diagnosis based on ACR criteria in randomized urine specimen

Exclusion criteria

Exclusion criteria: history of congestive heart failure,Infectious diseases of the urine, prostate,Acute febrile illnessUncontrolled blood pressureGlomerulonephritisPolycystic kidney disease,Acute hyperglycemia,The field of hereditary nephropathy Insulin therapy smoking Extreme sports activity (24 hours before sample collection) Pregnancy-lactation Use of any type of multi-vitamin supplement and so on during the study

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With Spectrophotometer.;Level of Serum Insulin. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With ELISA.;Homeostatic Model Assessment of Insulin Resistance(HOMA-IR). Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Calculated According to The Formula.;HbA1C. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With HPLC.;Total Cholestrol. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With Spectrophotometer.;HDL-C. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With Spectrophotometer.;LDL-C. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Calculated According to The Friedwald Formula.;TG. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With Spectrophotomete.;ICAM-1(Intra cellular adhesion molecule1). Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With ELISA.;VCAM-1( vascular cell adhesion molecule 1 ). Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: Blood Sampling and Analysing With ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham navval esfahlan

Tabriz University of Medical Sciences

elham.naval@gmail.com+98 413335758082

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026